Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ahidjo Ayouba is active.

Publication


Featured researches published by Ahidjo Ayouba.


Journal of Immunological Methods | 1998

Self-reactive antibodies (natural autoantibodies) in healthy individuals

Sébastien Lacroix-Desmazes; Srini V. Kaveri; Luc Mouthon; Ahidjo Ayouba; Evelyne Malanchère; Antonio Coutinho; Michel D. Kazatchkine

Antibodies that are present in the serum of healthy individuals in the absence of deliberate immunization with any antigen, are refered to as natural antibodies. A vast majority of natural antibodies react with one or more self antigens and are termed as natural autoantibodies. The importance of natural autoantibodies in immune regulation has long been neglected, since tolerance to self was thought to be primarily dependent on the deletion of autoreactive clones, rather than on peripheral suppressive mechanisms. Clonal deletion and energy cannot account, however, for the prevalence of natural autoreactivity among healthy individuals. It is now well established that autoreactive antibodies and B cells, and autoreactive T cells, are present in healthy individuals, and in virtually all vertebrate species. Autoreactive repertoires are predominantly selected early in ontogeny. Questions pertaining to the role of natural antibodies in the regulation of the immune response and maintenance of immune homeostasis and to the distinction between natural autoreactivity and pathological autoimmunity have not been adequately addressed. Here, we focus on the current knowledge on the physicochemical and functional properties of NAA in man, and the use of NAA for therapeutic intervention. reserved.


AIDS Research and Human Retroviruses | 2009

Low Prevalence of HIV Type 1 Drug Resistance Mutations in Untreated, Recently Infected Patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: The ANRS 12134 Study

Ahidjo Ayouba; Truong Xuan Lien; Janin Nouhin; Laurence Vergne; Avelin F. Aghokeng; Nicole Ngo-Giang-Huong; Halimatou Diop; Coumba Toure Kane; Diane Valéa; François Rouet; Dominique Joulia-Ekaza; Thomas Toni; Eric Nerrienet; Eitel Mpoudi Ngole; Eric Delaporte; Dominique Costagliola; Martine Peeters; Marie-Laure Chaix

The frequency of transmitted HIV drug resistance (HIVDR) was evaluated in the context of rapid scale-up of antiretroviral treatment in Thailand, Vietnam, Burkina Faso, Côte dIvoire, and Senegal by using an adaptation of the WHO generic protocol of the HIV Drug Resistance Threshold Survey (HIVDR-TS) for sample collection and classification. Resistance-associated mutations were interpreted using the 2009 WHO list for epidemiological surveys. We included 266 subjects from the five study sites. Of the 266 RT and PR sequences analyzed, two from Vietnam harbored virus with major drug resistance mutations (G190A in RT for one individual and M46I in PR for the second individual). Phylogenetic analysis revealed that CRF01_AE predominates (>90%) in Thailand and Vietnam. CRF02 (>65%) cocirculates with other HIV-1 variants in Senegal and Côte dIvoire. The prevalence of HIVDRM is scored as low (< or = 5%) in all the five sites for the three drug classes analyzed. A continuous population survey for HIVDRM will provide a rational basis for maintaining or changing the current first line regimen in these countries.


AIDS Research and Human Retroviruses | 2009

Low Prevalence of Drug Resistance Transmitted Virus in HIV Type 1-Infected ARV-Naive Patients in Cambodia

Janin Nouhin; Sopheak Ngin; P. Regis Martin; Olivier Marcy; Leangsim Kruy; Frédéric Ariey; Martine Peeters; Marie-Laure Chaix; Ahidjo Ayouba; Eric Nerrienet

Abstract Between November 2006 and June 2007, HIV-1 reverse transcriptase (RT) and protease (PR) genes of 67 ARV-naive Cambodian patients were amplified and sequenced. At inclusion, the median age and duration of HIV infection were 28 and 1.1 years, respectively. The median CD4 and HIV-1 RNA were 611 cells/ml [IQR: 525-759] and 4.0 log(10) copies/ml [IQR: 3.4-4.6]. Among 67 HIV-1 strains, 95.5% were CRF 01_AE viruses (n = 64) whereas three clustered with subtype B. RT analysis indicated that only 1 patient out of 67, presenting K103N and M184V mutations, was resistant to NVP/EFV and 3TC/FTC. No primary resistance to protease inhibitors was detected in 59 amplified protease genes. The 1.49% (IC 95%: 0.04-8.04%) prevalence of transmitted drug-resistant strains in drug-naive patients was low in our study. Surveys of drug-resistant transmitted viruses should be regularly performed regarding the increasing access to HAART in Cambodia.


Emerging Infectious Diseases | 2011

Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay.

Steve Ahuka-Mundeke; Ahidjo Ayouba; Placide Mbala-Kingebeni; Florian Liegeois; Amandine Esteban; Octavie Lunguya-Metila; Didace Demba; Guy Bilulu; Valentin Mbenzo-Abokome; Bila-Isia Inogwabini; Jean-Jacques Muyembe-Tamfum; Eric Delaporte; Martine Peeters

This assay identified new simian immunodeficiency viruses in primate bushmeat.


AIDS | 2008

Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum.

Ahidjo Ayouba; Cyril Badaut; Anfumbom Kfutwah; Claude Cannou; Alexandre Juillerat; Stéphane Gangnard; Charlotte Behr; Odile Mercereau-Puijalon; Graham A. Bentley; Françoise Barré-Sinoussi; Elisabeth Menu

Epidemiological data point to an increased risk of HIV-1 mother-to-child transmission in pregnant women with malaria, by unknown mechanisms. We show here that surface binding of a recombinant Plasmodium falciparum adhesin to chondroitin sulphate A proteoglycans increases HIV-1 replication in the human placental cell line BeWo, probably by a P. falciparum adhesin-induced long-terminal repeat-driven TNF-α stimulation. This suggests that placental malaria could increase the risk of HIV-1 transmission in utero.


Lancet Infectious Diseases | 2017

Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

Jean-François Etard; Mamadou Saliou Sow; Sandrine Leroy; Touré A; Bernard Taverne; Alpha Kabinet Keita; Philippe Msellati; N'Fally Magassouba; Sylvain Baize; Hervé Raoul; Suzanne Izard; C. Kpamou; Laura March; Ibrahima Savane; Moumié Barry; Eric Delaporte; Ahidjo Ayouba; Kaba Bangoura; Alimou Barry; Mamoudou Cissé; Mohammed Cissé; Jean-François Delfraissy; Christelle Delmas; Alice Desclaux; Saliou Bella Diallo; Mamadou Oury Safiatou Diallo; Mariama Sadjo Diallo; Jean François Étard; Cécile Etienne; Ousmane Faye

BACKGROUNDnThe high number of survivors from the 2013-16 west African outbreak of Ebola virus disease (EVD) has raised several new issues: long-term clinical complications, psychosocial consequences, risks of EVD reactivation, and secondary transmission due to viral persistence in body fluids. We aimed to assess long-term clinical, psychosocial, and viral outcomes in EVD survivors in Guinea.nnnMETHODSnIn this multidisciplinary observational cohort study, we recruited patients aged 1 year or more in four sites in Guinea (Donka National Hospital, Conakry; Macenta Prefectoral Hospital, Macenta; Nzérékoré Regional Hospital, Nzérékoré; and Forécariah Prefectoral Hospital, Forécariah) following discharge from any Ebola treatment centre in Guinea. Eligible patients had had laboratory-confirmed EVD and had then been declared clear of the virus in the blood. All consenting patients were included, with no exclusion criteria. Trained clinicians assessed patients at enrolment to the cohort, recording clinical symptoms and signs of depression. We did routine blood examinations and examined viral persistence in body fluids using RT-PCR. We did psychological evaluations using questionnaires developed for different age groups. Follow-up is planned to 2 years, and here we present findings at enrolment.nnnFINDINGSnBetween March 23, 2015, and July 11, 2016, we recruited 802 patients, of whom 360 (45%) were male, 442 (55%) were female; 158 (20%) were younger than 18 years. The median age was 28·4 years (range 1·0-79·9, IQR 19·4-39·8). The median delay after discharge was 350 days (IQR 223-491). The most frequent symptoms were general symptoms (324 [40%] patients), musculoskeletal pain (303 [38%]), headache (278 [35%]), depression (124 [17%] of 713 responses), abdominal pain (178 [22%]), and ocular disorders (142 [18%]). More adults than children had at least one clinical symptom (505 [78%] vs 101 [64%], p<0·0003), ocular complications (124 [19%] vs 18 [11%], p=0·0200), or musculoskeletal symptoms (274 [43%] vs 29 [18%], p<0·0001). A positive RT-PCR in semen was found in ten (5%) of 188 men, at a maximum of 548 days after disease onset. 204 (26%) of 793 patients reported stigmatisation. Ocular complications were more frequent at enrolment than at discharge (142 [18%] vs 61 [8%] patients).nnnINTERPRETATIONnPost-EVD symptoms can remain long after recovery and long-term viral persistence in semen is confirmed. The results justify calls for regular check-ups of survivors at least 18 months after recovery.nnnFUNDINGnINSERM/Reacting, the French Ebola Task Force, and Institut de Recherche pour le Développement.


Journal of the International AIDS Society | 2014

Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry

Abou Abdallah Malick Diouara; Halimatou Diop Ndiaye; Ibrehima Guindo; Nestor Bangoura; Mohamed Cissé; Tchiakpe Edmond; Flabou Bougoudogo; S. Mboup; Martine Peeters; Ahidjo Ayouba; Ndeye Coumba Toure Kane

Access to antiretroviral treatment (ART) becomes more and more effective in resource‐limited settings (RLS). However, this global effort would be even more profitable if the access to laboratory services especially in decentralized settings was strengthened. We report the virological outcome and HIV‐1 drug resistance in three West African countries using dried blood spots (DBS) samples.


Archive | 2002

Simian Immunodeficiency Viruses and the Origin of HIVs

Ousmane M. Diop; Aïssatou Guèye; Ahidjo Ayouba; Eric Nerrienet; Sylvie Corbet; Philippe Mauclère; François Simon; Françoise Barré-Sinoussi; Michaela Müller-Trutwin

Reconstruction of the phylogenetic relationships between the human lentiviruses responsible for the AIDS epidemic and lentiviruses from African nonhuman primates can help clarify the origin of the AIDS pandemic. These studies have several scientific—and public health—implications, although the detailed circumstances of such zoonotic events are still not fully understood. As the potential for simian-to-simian, simian-tohuman, and human-to-human transmission of lentiviruses becomes better understood, the emergence of new and/or more virulent lentiviral strains, capable of causing new epidemics, needs to be considered. Multidisciplinary field studies remain important. It also appears clear that studies of simian lentiviral infections can advance our understanding of HIV’s pathogenesis, an understanding necessary for the development of effective AIDS vaccines and therapeutics.


Viruses | 2015

High Rate of Simian Immunodeficiency Virus (SIV) Infections in Wild Chimpanzees in Northeastern Gabon

Vanina Boué; Sabrina Locatelli; Floriane Boucher; Ahidjo Ayouba; Christelle Butel; Amandine Esteban; Alain-Prince Okouga; Alphonse Ndoungouet; Peggy Motsch; Guillaume Le Flohic; Paul Ngari; Franck Prugnolle; Benjamin Ollomo; François Rouet; Florian Liegeois

The emergence of HIV-1 groups M, N, O, and P is the result of four independent cross-species transmissions between chimpanzees (cpz) and gorillas (gor) from central/south Cameroon and humans respectively. Although the first two SIVcpz were identified in wild-born captive chimpanzees in Gabon in 1989, no study has been conducted so far in wild chimpanzees in Gabon. To document the SIVcpz infection rate, genetic diversity, and routes of virus transmission, we analyzed 1458 faecal samples collected in 16 different locations across the country, and we conducted follow-up missions in two of them. We found 380 SIV antibody positive samples in 6 different locations in the north and northeast. We determined the number of individuals collected by microsatellite analysis and obtained an adjusted SIV prevalence of 39.45%. We performed parental analysis to investigate viral spread between and within communities and found that SIVs were epidemiologically linked and were transmitted by both horizontal and vertical routes. We amplified pol and gp41 fragments and obtained 57 new SIVcpzPtt strains from three sites. All strains, but one, clustered together within a specific phylogeographic clade. Given that these SIV positive samples have been collected nearby villages and that humans continue to encroach in ape’s territories, the emergence of a new HIV in this area needs to be considered.


Retrovirology | 2008

Prevalence of HIV-1 drug resistance mutations in antiretroviral naïve pregnant women from Cambodia, Cameroon, Central African Republic and Vietnam

Ahidjo Ayouba; Lenaig Le Fouler; Truong Tx Lien; Nary Ly; Valérie Maréchal; Aurélia Vessière; Anfumbom Kfutwah; Jean Marc Reynes; Elisabeth Menu; Eric Nerrienet; Muriel Vray; Hervé Fleury; Françoise Barré-Sinoussi

ss Open Acce Oral presentation Prevalence of HIV-1 drug resistance mutations in antiretroviral naive pregnant women from Cambodia, Cameroon, Central African Republic and Vietnam Ahidjo Ayouba*1, Lenaig Le Fouler2, Truong TX Lien3, Nary Ly4, Valerie Marechal5, Aurelia Vessiere1, Anfumbom Kfutwah1, Jean Marc Reynes4, Elisabeth Menu6, Eric Nerrienet1, Muriel Vray2, Herve Fleury7 and Francoise Barre-Sinoussi6

Collaboration


Dive into the Ahidjo Ayouba's collaboration.

Top Co-Authors

Avatar

Martine Peeters

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric Delaporte

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar

Florian Liegeois

Institut de recherche pour le développement

View shared research outputs
Top Co-Authors

Avatar

Steve Ahuka-Mundeke

Institut de recherche pour le développement

View shared research outputs
Top Co-Authors

Avatar

Amandine Esteban

Institut de recherche pour le développement

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge